Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 6,409.00
-80.50 (-1.24%)
Aug 5, 2025, 3:29 PM IST
Divi's Laboratories Employees
Divi's Laboratories had 10,542 employees as of March 31, 2025. The number of employees increased by 801 or 8.22% compared to the previous year.
Employees
10,542
Change (1Y)
801
Growth (1Y)
8.22%
Revenue / Employee
8.88M INR
Profits / Employee
2.08M INR
Market Cap
1,701.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10,542 | 801 | 8.22% |
| Mar 31, 2024 | 9,741 | 1,308 | 15.51% |
| Mar 31, 2023 | 8,433 | -8,110 | -49.02% |
| Mar 31, 2022 | 16,543 | -275 | -1.64% |
| Mar 31, 2021 | 16,818 | 2,934 | 21.13% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Cipla | 30,313 |
| Mankind Pharma | 26,978 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 18,785 |
Divi's Laboratories News
- 2 months ago - Morgan Stanley maintains overweight on Divis Labs, sees 11% upside after second global order win - Business Upturn
- 2 months ago - Divis Laboratories signs long-term supply deal with global pharma company - Business Upturn
- 2 months ago - BHEL, Hyundai & more: Top stocks on brokers' radar today - The Times of India
- 2 months ago - Stocks in news today: Divis Labs, Delhivery, Premier Energies, Zen Tech, KRBL, Galaxy Surfactants, Kaynes Tech after Q4 earnings on May 19 - Business Upturn
- 6 months ago - Divi's Laboratories Ltd (BOM:532488) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... - GuruFocus
- 6 months ago - Q3 2025 Divi's Laboratories Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Divi’s Labs remains our top pick, target price at Rs 6,850 after Q3 results: Citi - Business Upturn
- 8 months ago - Citi reaffirms ‘Buy’ on Divi’s Laboratories, sees buying opportunities amid BioSecure delays - Business Upturn